loading page

Is Magnesium Sulfate Treatment Really Effective in Moderate to Severe Bronchiolitis?
  • +7
  • İlknur Bodur,
  • Ayla Akca Caglar,
  • Aysun Tekeli,
  • Ali Güngör,
  • Muhammed Mustafa Güneylioglu,
  • Betül Ozturk,
  • Raziye Merve Yaradılmıs,
  • Aytac Goktug,
  • Can Demir Karacan,
  • Nilden Tuygun
İlknur Bodur
SBU Ankara Dr Sami Ulus Maternity Child Health and Diseases Training and Research Hospital
Author Profile
Ayla Akca Caglar
Ankara City Hospital
Author Profile
Aysun Tekeli
Ankara Gülhane Eğitim ve Araştırma Hastanesi
Author Profile
Ali Güngör
Dr Sami Ulus Gynecology Obstetrics and Child Health and Diseases Training and Research Hospital
Author Profile
Muhammed Mustafa Güneylioglu
SBU Ankara Dr Sami Ulus Maternity Child Health and Diseases Training and Research Hospital
Author Profile
Betül Ozturk
SBU Ankara Dr Sami Ulus Maternity Child Health and Diseases Training and Research Hospital
Author Profile
Raziye Merve Yaradılmıs
SBU Ankara Dr Sami Ulus Maternity Child Health and Diseases Training and Research Hospital
Author Profile
Aytac Goktug
SBU Ankara Dr Sami Ulus Maternity Child Health and Diseases Training and Research Hospital
Author Profile
Can Demir Karacan
SBU Ankara Dr Sami Ulus Maternity Child Health and Diseases Training and Research Hospital
Author Profile
Nilden Tuygun
SBU Ankara Dr Sami Ulus Maternity Child Health and Diseases Training and Research Hospital
Author Profile

Abstract

Objectives: The aim of our study is to examine the efficacy and safety of intravenous magnesium sulfate in moderate-severe acute bronchiolitis. Working hypothesis: Intravenous magnesium sulfate treatment may be effective in the treatment of patients with bronchiolitis . Study design: Retrospective, single-center cohort study Methodology: We conducted a study in 150 infants presenting with moderate to severe acute bronchiolitis. A total of 150 infants aged 1 month to 2 years who presented with acute bronchiolitis to our pediatric emergency department between January 2018 and March 2019 were admitted into the study. The demographic characteristics, clinical score, and management of the patients were examined. Results: A total of 150 infants were analyzed: 62 in the magnesium sulfate group (Group I) and 88 in the supportive care group (Group II). Baseline clinical characteristics were similar in both groups. Length of hospitalization was significantly shorter in Group II. Clinical severity scores were also lower significantly earlier in Group I (p=0.031, p=0.008, respectively at first and fourth hour). Conclusions: Intravenous magnesium treatment in moderateto severe acute bronchiolitis does not appear to conferany significant decrease in clinical severity scores when compared to only supportive care